Focus: DEM BioPharma is a cell therapy company focused on leveraging the 'Don't Eat Me' signal to advance treatments in gene and cell therapy. Based in Cambridge, MA, the company operates at the preclinical/early-stage biotech segment.
Profile data last refreshed 9m ago · AI intelligence enriched 2w ago
No open roles listed right now. Follow DEM BioPharma to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
No open positions listed yet. Check their careers page directly.
Based on last 4 crawl cycles
Help build intelligence for DEM BioPharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from DEM BioPharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo